Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Buyers Remorse: Merck & Co. Takes $2.9 Billion Charge on Hepatitis C Drug Inherited From $3.9 Billion Idenix Buy

Merck took a pre-tax $2.9 billion hit from its flagging hepatitis C drug candidate uprifosbuvir due to flagging sales in the market, in part due to the success of drugs already available, which would include Gilead Sciences’ Harvoni and Sovaldi treatments.

Read More »

Scientists test deep brain stimulation as potential anorexia therapy

A small study in 16 people with severe anorexia has found that implanting stimulation electrodes into the brains of patients could ease their anxiety and help them gain weight.

Read More »

Merck drug prevents serious infection after marrow transplant: study

An experimental Merck drug succeeded in preventing clinically serious cytomegalovirus following bone marrow transplant and was associated with a lower death rate compared with placebo.

Read More »

Boston Scientific recalls all Lotus Valve heart devices

Boston Scientific Corp. said the company was recalling its Lotus range of heart devices, citing reports of problems with the locking mechanism, sending its shares down 7.3 percent in morning trading.

Read More »

Depression top cause of disability, strikes young and old: WHO

More than 4 percent of the world’s population lives with depression, and women, youth and the elderly are the most prone to its disabling effects, the World Health Organization (WHO) said.

Read More »

Cyclacel’s leukemia drug fails in key study

Cyclacel Pharmaceuticals Inc. said its lead experimental drug did not help elderly patients with acute myeloid leukemia live longer in a late-stage study.

Read More »

The End of the Road: NovaDel Pharma to Dissolve

After taking more than a year to sell off its insomnia medication ZolipiMist to Amherst Pharmaceuticals, NovaDel Pharma has dissolved the company.

Read More »

Medical Advertising Hall of Fame 2017

Ryan Abbate and Mike Lazur were honored as the 2017 inductees for the Medical Advertising Hall of Fame black-tie event held on Feb. 22 at The Pierre Hotel in New York City.

Read More »

Roche Reports Death in Phase III Hemophilia Study

Swiss-based Roche reported a death in its ACE910 study of emicizumab in patients with hemophilia A and factor VIII inhibitors.

Read More »

Novartis cancer drug Zykadia gets FDA priority review

The U.S. Food and Drug Administration (FDA) has granted priority review to the Novartis drug Zykadia as a first-line treatment for some lung cancer patients, the Swiss drugmaker said.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom